HRTX
Heron Therapeutics Inc
Price:  
3.60 
USD
Volume:  
1,314,544.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

HRTX EV/EBITDA

-411.1%
Upside

As of 2024-06-16, the EV/EBITDA ratio of Heron Therapeutics Inc (HRTX) is -8.60. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. HRTX's latest enterprise value is 671.43 mil USD. HRTX's TTM EBITDA according to its financial statements is -78.11 mil USD. Dividing these 2 quantities gives us the above HRTX EV/EBITDA ratio.

Note: valuation result may not be accurate due to the company's negative EBITDA.

Range Selected
Trailing P/E multiples 13.4x - 18.3x 18.2x
Forward P/E multiples 18.3x - 22.5x 21.7x
Fair Price (10.32) - (10.33) (11.20)
Upside -386.8% - -387.1% -411.1%
3.60 USD
Stock Price
(11.20) USD
Fair Price

HRTX EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2024-06-14 -8.60
2024-06-13 -8.66
2024-06-12 -8.71
2024-06-11 -8.67
2024-06-10 -8.77
2024-06-07 -8.60
2024-06-06 -8.65
2024-06-05 -9.02
2024-06-04 -8.60
2024-06-03 -9.10
2024-05-31 -8.79
2024-05-30 -8.31
2024-05-29 -7.96
2024-05-28 -8.23
2024-05-24 -8.29
2024-05-23 -8.35
2024-05-22 -8.35
2024-05-21 -8.29
2024-05-20 -8.21
2024-05-17 -7.82
2024-05-16 -7.86
2024-05-15 -7.44
2024-05-14 -7.07
2024-05-13 -7.08
2024-05-10 -7.00
2024-05-09 -7.32
2024-05-08 -7.46
2024-05-07 -7.19
2024-05-06 -7.13
2024-05-03 -6.69
2024-05-02 -6.57
2024-05-01 -6.17
2024-04-30 -6.13
2024-04-29 -6.47
2024-04-26 -6.38
2024-04-25 -6.57
2024-04-24 -6.76
2024-04-23 -7.05
2024-04-22 -6.65
2024-04-19 -6.74
2024-04-18 -6.88
2024-04-17 -7.00
2024-04-16 -7.30
2024-04-15 -7.34
2024-04-12 -7.27
2024-04-11 -7.32
2024-04-10 -6.92
2024-04-09 -7.05
2024-04-08 -6.96
2024-04-05 -6.96